Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov revision label from v3.5.2 to v3.5.3, indicating a site/application version update rather than any change to the study details.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoChange DetectedNew update dates 2026-04-08 and 2026-04-09 were added, and 2026-04-01 and 2026-04-02 were removed. This reflects chronology updates to the study record.SummaryDifference0.1%

- Check33 days agoChange DetectedThe study record shows new update entries for 2026-04-02 and 2026-04-01 and deletions for 2026-03-25 and 2026-03-24.SummaryDifference0.1%

- Check40 days agoChange DetectedAdministrative updates were made to the study record dates, adding 2026-03-25 and 2026-03-24 and removing 2026-03-18 and 2026-03-19.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded Informed Consent Form PDFs for Phase I, Phase 2A, and Phase 2B under Study Documents. The revision version is v3.5.0.SummaryDifference0.9%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.